- Home
- MKZR vs PTHL Comparison
MKZR vs PTHL Comparison
Compare MKZR & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MKZR | PTHL |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 8.8M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | MKZR | PTHL |
|---|---|---|
| Price | $4.72 | $0.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 48.9K | ★ 55.9K |
| Earning Date | 02-11-2026 | 03-20-2026 |
| Dividend Yield | ★ 11.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $20,994,778.00 | $305,215.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.63 | N/A |
| 52 Week Low | $3.26 | $0.42 |
| 52 Week High | $31.80 | $32.00 |
Technical Indicators
Market Signals| Indicator | MKZR | PTHL |
|---|---|---|
| Relative Strength Index (RSI) | 62.04 | 42.64 |
| Support Level | $3.75 | $0.42 |
| Resistance Level | $4.72 | $0.50 |
| Average True Range (ATR) | 0.38 | 0.04 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 100.00 | 51.92 |
Price Performance
Historical ComparisonAbout MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate. It is a real estate investment manager who utilizes an approach to real estate securities, often seeing opportunities that others overlook. Based in Orinda, California, MacKenzie Capital Management has specialized in discounted real estate securities and asset management.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.